Sammaan Capital Ltd.
ISIN: INE148I01020 • Market Cap: ₹17,893 Cr
The 5-Pillar Quality Audit for Sammaan Capital Ltd.
Evaluated across Profitability, Financial Health, Historical Compounding, Valuation Safety, and Ownership Governance:
1. Profitability & Capital Efficiency
Weight: 25%Measures operating margins (45.5%), Return on Capital Employed (4.3%), and equity compounding (—).
2. Financial Health & Solvency
Weight: 25%Debt-to-Equity is 1.98 with comfortable interest coverage and clean working capital.
3. Growth & Compounding Track Record
Weight: 20%Historical 3Y Sales CAGR (-5.3%) and 3Y PAT CAGR (—).
4. Valuation Multiple & Margin of Safety
Weight: 15%Trades at P/E of — vs PEG of — and Dividend Yield of —.
5. Ownership Quality & Governance
Weight: 15%Promoter holding stands at 28.3%, backed by 27.6% institutional ownership.
Key Fundamental Strengths
Deep Institutional Sponsorship (27.6%)
Mutual funds, domestic DIIs, and foreign FIIs hold 27.6%, providing strong governance scrutiny.
Consistent Market Standing (Mid Cap)
Established player in the Financial Services sector with an overall fundamental quality score of 40/100.
Areas to Watch & Potential Risks
Subdued Capital Efficiency (ROCE: 4.3%)
A sub-12% ROCE suggests return on capital barely exceeds the company's weighted average cost of capital (WACC).
Elevated Financial Gearing (D/E: 1.98)
Debt-to-Equity exceeds 0.9x, meaning substantial operating earnings are absorbed by mandatory interest coverage.
Topline Stagnation (3Y Sales CAGR: -5.3%)
Revenue growth has slowed below inflation rates, indicating cyclical demand slowdown or saturated core markets.
Quantitative Strategy Eligibility
Checking SAMMAANCAP against established Indian wealth creation frameworks:
Coffee Can Investing Framework
Fails 10%+ revenue growth or 15%+ minimum capital return benchmark over historical periods.
Quality Factor Screener (High RoIC + Low Debt)
Scorecard of 40/100 or leverage profile sits below strict quality index hurdles.
GARP / Value-Growth Blend
Valuation multiple or return metrics require further cyclical pullback.
Financial Services Sector Peer Comparison
Compare SAMMAANCAP directly against top industry peers by market capitalization:
| Company | 5-Pillar Score | Market Cap | P/E | ROCE | D/E | Scorecard |
|---|---|---|---|---|---|---|
| Sammaan Capital Ltd. (SAMMAANCAP)Current | 40/100 | ₹17,893 Cr | — | 4.3% | 1.98 | — |
| HDFC Bank Ltd. (HDFCBANK) | 74/100 | ₹11.10 Lakh Cr | 14.05 | 12.8% | 1.01 | View |
| ICICI Bank Ltd. (ICICIBANK) | 76/100 | ₹10.06 Lakh Cr | 17.94 | 16.5% | 0.62 | View |
| State Bank of India (SBIN) | 71/100 | ₹9.66 Lakh Cr | 11.20 | 12.2% | 1.38 | View |
| Bajaj Finance Ltd. (BAJFINANCE) | 68/100 | ₹6.72 Lakh Cr | 33.07 | 13.9% | 3.86 | View |
| Life Insurance Corporation of India (LICI) | 87/100 | ₹5.22 Lakh Cr | 8.70 | 37.8% | 0.00 | View |
Frequently Asked Questions: Sammaan Capital Ltd.
Q:What is the 5-Pillar Fundamental Score for Sammaan Capital Ltd. (SAMMAANCAP)?
Sammaan Capital Ltd. has a RupeeTools Fundamental Score of 40/100, placing it in the 'Caution / Risky' category. Its pillar scores are: Profitability (53/100), Financial Health (46/100), Growth (20/100), Valuation (15/100), and Ownership Quality (60/100).
Q:Is SAMMAANCAP fundamentally strong for long-term investment?
SAMMAANCAP currently holds a moderate quality rating of 40/100. While it operates in the Financial Services sector, investors should monitor its debt health before initiating long-term positions.
Q:Does SAMMAANCAP pass the Coffee Can Investing filter?
No. SAMMAANCAP does not currently meet the strict 15% ROCE and 10% sustained topline compounding threshold mandated by the Coffee Can investing framework.
Q:How does SAMMAANCAP compare against other Financial Services peers?
Within India's Financial Services sector, SAMMAANCAP trades at a P/E of — and generates an ROCE of 4.3%. Compare its 5-Pillar score of 40/100 against top sector peers like HDFC Bank Ltd. (74/100), ICICI Bank Ltd. (76/100).
Regulatory & SEBI Research Analyst Compliance Disclaimer:
This 5-pillar fundamental score is an automated quantitative health check generated purely from historical public financial statements, corporate filings, and exchange disclosures for educational and informational purposes only. It does NOT constitute investment advice, a stock recommendation, or a solicitation to buy or sell securities. RupeeTools is not a SEBI-registered Research Analyst. Please consult a SEBI-registered financial advisor before making investment decisions.